Stoke Therapeutics, Inc. (STOK) — Revenue

Annual figures by fiscal year, from SEC filings.

2022: $12.40M2023: $8.78M2024: $36.55M2025: $184.42M$184.42M
2022Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$184.42M+404.5%
2024$36.55M+316.3%
2023$8.78M-29.2%
2022$12.40M